Ruxolitinib vs Ryoncil, page-3

  1. 92 Posts.
    lightbulb Created with Sketch. 93
    I did a comparision of the two trials in a different thread which ill copy below:

    Lets do a comparison of Ruxolitnib vs Remestemcel-L trials:
    Trial:
    • Single arm open label 49 patients
    • Single arm open label 54 patients (Study 001)
    Day 28 ORR:
    • 40.7%-44.4% on grade 3-4 (grade c-d)
    • 61%-67% on grade 3-4 (grade c-d)
    Day 180 Survival:
    • 51% (n=25)
    • 69% (n=37)
    Safety:
    • Multiple safety concerns/side effects including infections, sepsis, uti's, thrombosis and animia (adverse events lead to 31% of patients discontinuing treatment)
    • No safety concerns identified with a safety profile similar to placebo (adverse events lead to 15% of patients discontinuing treatment)
    FDA Decision
    • Approved
    • ODAC voted 9-1 in favour of efficacy however FDA issued a CRL recommending a further trial to establish efficacy and to provide more scientific rationale to demonstrate potency relationships

    Ruxolitnib has had a previous trial for the treatment of myelofibrosis. The trial results clearly show that from the available data, Remestemcel-L is a superior treatment with a much better safety profile.

    Could msb argue that if the COVID-19 trial is successful this would provide sufficient evidence of relevant efficacy and safety similar to Ruxolitnib extension from myelofibrosis to GvHD based on the 1 single arm trial above?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.28
Change
-0.030(1.30%)
Mkt cap ! $2.918B
Open High Low Value Volume
$2.32 $2.39 $2.24 $13.10M 5.680M

Buyers (Bids)

No. Vol. Price($)
8 44474 $2.27
 

Sellers (Offers)

Price($) Vol. No.
$2.29 30176 3
View Market Depth
Last trade - 16.17pm 22/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.